Source: The Ohio State University College of Veterinary Medicine
A new clinical trial is underway to evaluate a promising treatment for acute pancreatitis, a painful and potentially life-threatening condition affecting both dogs and humans. Led by Lamassu Pets and The Ohio State University College of Veterinary Medicine, the study is testing RABI-767, a novel drug designed to reduce symptoms, complications, and organ failure through a single injection near the pancreas.
Supported by the National Institutes of Health, the trial aims to identify effective treatment and dosing strategies for dogs while advancing translational research that could benefit human patients as well. Early data suggest the drug may reduce mortality and severity of the disease. Researchers emphasize the dual impact of the study, offering hope for improved care in Veterinary and human medicine alike.